Abstract:The process of drug development is expensive and time-consuming. In contrast, drug repurposing can be introduced to clinical practice more quickly and at a reduced cost. Over the last decade, there has been a significant expansion of large biobanks that link genomic data to electronic health record data, public availability of various databases containing biological and clinical information and rapid development of novel methodologies and algorithms in integrating different sources of data. This review aims to provide a thorough summary of different strategies that utilize genomic data to seek drug-repositioning opportunities. We searched MEDLINE and EMBASE databases to identify eligible studies up until 1 May 2023, with a total of 102 studies finally included after two-step parallel screening. We summarized commonly used strategies for drug repurposing, including Mendelian randomization, multi-omic-based and network-based studies and illustrated each strategy with examples, as well as the data sources implemented. By leveraging existing knowledge and infrastructure to expedite the drug discovery process and reduce costs, drug repurposing potentially identifies new therapeutic uses for approved drugs in a more efficient and targeted manner. However, technical challenges when integrating different types of data and biased or incomplete understanding of drug interactions are important hindrances that cannot be disregarded in the pursuit of identifying novel therapeutic applications. This review offers an overview of drug repurposing methodologies, providing valuable insights and guiding future directions for advancing drug repurposing studies.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is that in the drug development process, traditional methods are costly and time - consuming, while drug repurposing can be introduced into clinical practice more quickly and discover new therapies at a lower cost. Specifically, this review aims to provide a comprehensive summary of how different strategies utilize human genomic data to find opportunities for drug repurposing. These strategies include Mendelian randomization (MR), multi - omic - based studies, and network - based studies. By integrating existing knowledge and infrastructure, drug repurposing can identify new therapeutic uses of approved drugs in a more efficient and targeted manner. However, technical challenges and a biased or incomplete understanding of drug interactions remain important obstacles to identifying new therapeutic applications. This review provides an overview of drug repurposing methods and offers valuable insights and guidance for future research directions. ### Key Point Summary: 1. **Problem Background**: - The drug development process is expensive and time - consuming. - Drug repurposing can be introduced into clinical practice more quickly and discover new therapies at a lower cost. 2. **Research Objectives**: - Provide a comprehensive summary of how different strategies utilize human genomic data to find opportunities for drug repurposing. - Evaluate the advantages and limitations of different strategies. - Provide guidance and suggestions for future drug repurposing research. 3. **Main Strategies**: - **Mendelian randomization (MR)**: Use genetic variation as an instrumental variable to evaluate the causal relationship between potential therapeutic targets and outcomes. - **Multi - omic - based studies**: Integrate multiple omics data such as genomics, transcriptomics, proteomics, and metabolomics to explore disease mechanisms and identify new drug targets. - **Based on network - based studies**: Utilize complex biological networks to integrate information on variation, genes, proteins, disease outcomes, and drugs, revealing new relationships among drugs, diseases, and molecular targets. 4. **Data Sources**: - Large - scale cohort studies and GWAS consortia, such as UK Biobank, 23andMe, etc. - The databases used in network strategies include not only population data but also drug information, clinical information, and biological mechanism information, such as DGIdb, ClinicalTrials.gov, STRING, etc. 5. **Challenges and Suggestions**: - Technical challenges: Technical difficulties faced when integrating different types of data. - Data quality and availability: Differences in the quality and availability of different data sources. - Biological complexity: The high complexity of biological systems may lead to incomplete understanding. - Selecting an appropriate strategy: Select an appropriate drug repurposing strategy according to the research objective and data nature. This review provides a valuable resource for researchers in the field of drug repurposing and helps to promote the further development of this field.

The landscape of the methodology in drug repurposing using human genomic data: a systematic review

DrugRepo: a novel approach to repurposing drugs based on chemical and genomic features

Drug repurposing: progress, challenges and recommendations

An Analytical Review of Computational Drug Repurposing

Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases

Repurposing of Drugs: Updates and New Perspectives

A Study on Methodologies of Drug Repositioning Using Biomedical Big Data: A Focus on Diabetes Mellitus

Integrating gene expression and clinical data to identify drug repurposing candidates for hyperlipidemia and hypertension

System biology approaches for drug repurposing

Drug Repurposing: Far Beyond New Targets for Old Drugs

Computational drug repurposing based on electronic health records: a scoping review

Computational repurposing of oncology drugs through off‐target drug binding interactions from pharmacological databases

Drug Repurposing: An Effective Tool in Modern Drug Discovery

Drug Repurposing of Generic Drugs: Challenges and the Potential Role for Government

Drug repositioning: A bibliometric analysis

Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines

Drug Repurposing: A Leading Strategy for New Threats and Targets

Current approaches in identification of a novel drug targets for drug repurposing

Repurposing – second life for drugs

Drug repurposing—an emerging strategy in cancer therapeutics

DrugRepoBank: a comprehensive database and discovery platform for accelerating drug repositioning